-
Product Insights
New![]()
Likelihood of Approval and Phase Transition Success Rate Model – Divarasib in Anal Cancer
OverviewHow likely is it that a drug will get approved? Will the drug transition to the next phase of its clinical pathway? This report provides you with the data that allows you to track and predict the specific likelihood of approval (LOA) and phase transition success rate (PTSR) of a drug using GlobalData's proprietary machine learning algorithms developed using over 10 years of historical data.Divarasib in Anal CancerDrug Details:Divarasib (GDC-6036 (RG6330)) is under development for the treatment of metastatic or...
-
Product Insights
New![]()
Likelihood of Approval and Phase Transition Success Rate Model – TmPSMA 01 CAR-T in Metastatic Castration-Resistant Prostate Cancer (mCRPC)
Overview How likely is it that a drug will get approved? Will the drug transition to the next phase of its clinical pathway? This report provides you with the data that allows you to track and predict the specific likelihood of approval (LOA) and phase transition success rate (PTSR) of a drug using GlobalData's proprietary machine learning algorithms developed using over 10 years of historical data. TmPSMA 01 CAR-T in Metastatic Castration-Resistant Prostate Cancer (mCRPC) Drug Details: TmPSMA 01 CAR-T...
-
Product Insights
New![]()
Likelihood of Approval and Phase Transition Success Rate Model – Daridorexant Hydrochloride in Obstructive Sleep Apnea
How likely is it that a drug will get approved? Will the drug transition to the next phase of its clinical pathway? This report provides you with the data that allows you to track and predict the specific likelihood of approval (LOA) and phase transition success rate (PTSR) of a drug using GlobalData's proprietary machine learning algorithms developed using over 10 years of historical data. Daridorexant Hydrochloride in Obstructive Sleep Apnea Drug Details: Daridorexant Hydrochloride (Quviviq) is under development for...
-
Product Insights
New![]()
Likelihood of Approval and Phase Transition Success Rate Model – CK1 Alpha Degrader in Hematological Tumor
How likely is it that a drug will get approved? Will the drug transition to the next phase of its clinical pathway? This report provides you with the data that allows you to track and predict the specific likelihood of approval (LOA) and phase transition success rate (PTSR) of a drug using GlobalData's proprietary machine learning algorithms developed using over 10 years of historical data. CK1 Alpha Degrader in Hematological Tumor Drug Details: CK1 alpha degrader is under development for...
-
Product Insights
New![]()
Likelihood of Approval and Phase Transition Success Rate Model – M-ceNK in Solid Tumor
Overview How likely is it that a drug will get approved? Will the drug transition to the next phase of its clinical pathway? This report provides you with the data that allows you to track and predict the specific likelihood of approval (LOA) and phase transition success rate (PTSR) of a drug using GlobalData's proprietary machine learning algorithms developed using over 10 years of historical data. M-ceNK in Solid Tumor Drug Details: Cellular Immunotherapy is under development for the treatment...
-
Product Insights
New![]()
Likelihood of Approval and Phase Transition Success Rate Model – Designer Edv in Solid Tumor
Overview How likely is it that a drug will get approved? Will the drug transition to the next phase of its clinical pathway? This report provides you with the data that allows you to track and predict the specific likelihood of approval (LOA) and phase transition success rate (PTSR) of a drug using GlobalData’s proprietary machine learning algorithms developed using over 10 years of historical data. Designer Edv in Solid Tumor Drug Details: Designer EDV is under development for the...
-
Product Insights
New![]()
Likelihood of Approval and Phase Transition Success Rate Model – GSK-4381562 in Breast Cancer
OverviewHow likely is it that a drug will get approved? Will the drug transition to the next phase of its clinical pathway? This report provides you with the data that allows you to track and predict the specific likelihood of approval (LOA) and phase transition success rate (PTSR) of a drug using GlobalDatas proprietary machine learning algorithms developed using over 10 years of historical data.GSK-4381562 in Breast Cancer Drug Details:GSK4381562 is under development for the treatment of solid tumors including...
-
Product Insights
New![]()
Likelihood of Approval and Phase Transition Success Rate Model – Kid Edv in Solid Tumor
OverviewHow likely is it that a drug will get approved? Will the drug transition to the next phase of its clinical pathway? This report provides you with the data that allows you to track and predict the specific likelihood of approval (LOA) and phase transition success rate (PTSR) of a drug using GlobalDatas proprietary machine learning algorithms developed using over 10 years of historical data.Kid EDV in Solid Tumor Drug Details:Kid EDV is under development for the treatment of recurrent...
-
Product Insights
New![]()
Likelihood of Approval and Phase Transition Success Rate Model – Volagidemab in Type 1 Diabetes (Juvenile Diabetes)
OverviewHow likely is it that a drug will get approved? Will the drug transition to the next phase of its clinical pathway? This report provides you with the data that allows you to track and predict the specific likelihood of approval (LOA) and phase transition success rate (PTSR) of a drug using GlobalDatas proprietary machine learning algorithms developed using over 10 years of historical data.Volagidemab in Type 1 Diabetes (Juvenile Diabetes) Drug Details:Volagidemab (REMD-477, AMG-477) is under development for treatment...
-
Product Insights
New![]()
Likelihood of Approval and Phase Transition Success Rate Model – GH-001 in Treatment Resistant Depression
OverviewHow likely is it that a drug will get approved? Will the drug transition to the next phase of its clinical pathway? This report provides you with the data that allows you to track and predict the specific likelihood of approval (LOA) and phase transition success rate (PTSR) of a drug using GlobalData's proprietary machine learning algorithms developed using over 10 years of historical data.GH-001 in Treatment Resistant DepressionDrug Details:GH-001 is under development for the treatment of treatment-resistant depression, major...
Sign up to receive regular alerts for our latest analysis and reports. No matter your industry focus, you can keep your finger on the pulse with our timely updates.